OPKO Health (OPK) Tops Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.72 --0%
Revenue Growth %: -9.9%
Financial Fact:
Income tax (benefit) provision: 19.99M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: -9.9%
Financial Fact:
Income tax (benefit) provision: 19.99M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q4 EPS of $0.01, $0.09 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $103.1 million versus the consensus estimate of $156.35 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grainger (GWW) Tops Q3 EPS by 87c ; Offers Guidance
- Medline Inc. (MDLN) Reports Q3 EPS of $0.44
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
